<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/"><channel><title>心血管出版物</title><link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_medium=rss&amp;ff=20231003060854&amp;v=2.17.9.post6+86293ac&amp;utm_campa ign= pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_source=铬&amp;fc =20230708114047<description>心血管亮点：PubMed 的最新结果</description><atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_medium=rss&amp;ff=20231003060854&amp;v=2.17.9.post6+86293ac&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_source=Chrome&amp;fc=20230708114047" rel="self"></atom:link><docs> http://www.rssboard.org/rss-specification</docs><generator> PubMed RSS 源 (2.17.9.post6+86293ac)</generator><language> zh</language><lastbuilddate> 2023 年 10 月 3 日，星期二 10:08:55 +0000</lastbuilddate><pubDate> Mon, 02 Oct 2023 06:00:00 -0400</pubDate><ttl> 120</ttl><item><title>高海拔心血管生理学和病理生理学</title><link/>https://pubmed.ncbi.nlm.nih.gov/37783743/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff =20231003060854&amp;v=2.17.9.post6+86293ac<description>氧气对细胞代谢至关重要，因此，高原缺氧会影响所有生理功能。急性缺氧会激活肾上腺素能系统，诱发心动过速，而缺氧肺血管收缩会增加肺动脉压力。在低氧浓度下暴露几天后，自主神经系统适应，心动过速减少，从而保护心肌免受高能量消耗。永久暴露... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Nat Rev Cardiol。2023 年 10 月 2 日。doi：10.1038/s41569-023-00924-9。印刷前在线。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">氧气对细胞代谢至关重要，因此，高原缺氧会影响所有生理功能。急性缺氧会激活肾上腺素能系统，诱发心动过速，而缺氧肺血管收缩会增加肺动脉压力。在低氧浓度下暴露几天后，自主神经系统适应，心动过速减少，从而保护心肌免受高能量消耗。长期暴露在高海拔地区会导致红细胞生成，如果过多，可能是有害的，并导致慢性高山病，通常与肺动脉高压和心力衰竭有关。遗传不同的人口和地理区域可能会导致慢性高山病患病率的差异。心血管对缺氧的适应提供了细胞和全身水平氧气供应调节的显着模型。快速暴露在高海拔地区可能会产生不利影响心血管疾病患者。然而，间歇性、中度缺氧可能有助于治疗某些心血管疾病，如冠心病和心力衰竭。本综述的目的是帮助医生了解心血管对缺氧的反应，并了解概述了他们可以向希望前往高海拔目的地的心血管疾病患者提供的一些建议。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37783743/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231003060854&v=2.17.9.post6+86293ac">37783743</a> | DOI： <a href=https://doi.org/10.1038/s41569-023-00924-9>10.1038/s41569-023-00924-9</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37783743</guid><pubDate> Mon, 02 Oct 2023 06:00:00 -0400</pubDate><dc:creator>让-保罗·里查莱特</dc:creator><dc:creator>埃里克·赫曼德</dc:creator><dc:creator>弗朗索瓦·J·卢西埃</dc:creator><dc:date>2023-10-02</dc:date><dc:source> 《自然》评论、心脏病学</dc:source><dc:title>高海拔心血管生理学和病理生理学</dc:title><dc:identifier>下午:37783743</dc:identifier><dc:identifier> doi:10.1038/s41569-023-00924-9</dc:identifier></item><item><title>发酵食品和饮料对心血管的益处：仍有争议</title><link/>https://pubmed.ncbi.nlm.nih.gov/37783744/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff =20231003060854&amp;v=2.17.9.post6+86293ac<description>无摘要</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Nat Rev Cardiol。2023 年 10 月 2 日。doi：10.1038/s41569-023-00938-3。印刷前在线。</p><p><b>无摘要</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37783744/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231003060854&v=2.17.9.post6+86293ac">37783744</a> | DOI： <a href=https://doi.org/10.1038/s41569-023-00938-3>10.1038/s41569-023-00938-3</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37783744</guid><pubDate> Mon, 02 Oct 2023 06:00:00 -0400</pubDate><dc:creator>拉蒙·埃斯特鲁奇</dc:creator><dc:creator>罗莎·M·拉穆埃拉-拉文托斯</dc:creator><dc:date>2023-10-02</dc:date><dc:source> 《自然》评论、心脏病学</dc:source><dc:title>发酵食品和饮料对心血管的益处：仍有争议</dc:title><dc:identifier>下午：37783744</dc:identifier><dc:identifier> doi:10.1038/s41569-023-00938-3</dc:identifier></item><item><title>心血管护理的基于价值的支付：触及问题的核心</title><link/>https://pubmed.ncbi.nlm.nih.gov/37782698/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff =20231003060854&amp;v=2.17.9.post6+86293ac<description>无摘要</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>流通</b>. 2023 年 10 月 3 日；148(14):1084-1086. doi: 10.1161/CIRCULATIONAHA.123.065661. Epub 2023 年 10 月 2 日。</p><p><b>无摘要</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37782698/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231003060854&v=2.17.9.post6+86293ac">37782698</a> | DOI： <a href=https://doi.org/10.1161/CIRCULATIONAHA.123.065661>10.1161 / CIRCULATIONAHA.123.065661</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37782698</guid><pubDate> Mon, 02 Oct 2023 06:00:00 -0400</pubDate><dc:creator>里希·K·瓦德拉</dc:creator><dc:date>2023-10-02</dc:date><dc:source>循环</dc:source><dc:title>心血管护理的基于价值的支付：触及问题的核心</dc:title><dc:identifier>下午:37782698</dc:identifier><dc:identifier> doi:10.1161/循环AHA.123.065661</dc:identifier></item><item><title>获得性因子 VIII 缺乏症导致的出血和心肌梗死</title><link/>https://pubmed.ncbi.nlm.nih.gov/37782697/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff =20231003060854&amp;v=2.17.9.post6+86293ac<description>无摘要</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>流通</b>. 2023 年 10 月 3 日；148(14):1127-1133. doi: 10.1161/CIRCULATIONAHA.123.063904. Epub 2023 年 10 月 2 日。</p><p><b>无摘要</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37782697/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231003060854&v=2.17.9.post6+86293ac">37782697</a> | DOI： <a href=https://doi.org/10.1161/CIRCULATIONAHA.123.063904>10.1161/CIRCULATIONAHA.123.063904</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37782697</guid><pubDate> Mon, 02 Oct 2023 06:00:00 -0400</pubDate><dc:creator>约瑟夫·M·金</dc:creator><dc:creator>罗伯特·M·斯特恩</dc:creator><dc:creator>布拉德利·马龙</dc:creator><dc:date>2023-10-02</dc:date><dc:source>循环</dc:source><dc:title>获得性因子 VIII 缺乏症导致的出血和心肌梗死</dc:title><dc:identifier>下午:37782697</dc:identifier><dc:identifier> doi:10.1161/循环AHA.123.063904</dc:identifier></item><item><title>慢性冠状动脉粥样硬化患者开始抗炎治疗的时机已经到来</title><link/>https://pubmed.ncbi.nlm.nih.gov/37782696/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff =20231003060854&amp;v=2.17.9.post6+86293ac<description>无摘要</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>流通</b>. 2023 年 10 月 3 日；148(14):1071-1073.doi: 10.1161/CIRCULATIONAHA.123.066510.Epub 2023 年 10 月 2 日。</p><p><b>无摘要</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37782696/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231003060854&v=2.17.9.post6+86293ac">37782696</a> | DOI： <a href=https://doi.org/10.1161/CIRCULATIONAHA.123.066510>10.1161 / CIRCULATIONAHA.123.066510</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37782696</guid><pubDate> Mon, 02 Oct 2023 06:00:00 -0400</pubDate><dc:creator>保罗·M·里德克</dc:creator><dc:date>2023-10-02</dc:date><dc:source>循环</dc:source><dc:title>慢性冠状动脉粥样硬化患者开始抗炎治疗的时机已经到来</dc:title><dc:identifier>下午:37782696</dc:identifier><dc:identifier> doi:10.1161/循环AHA.123.066510</dc:identifier></item><item><title>心源性休克研究和机械循环支持装置的标准化定义：休克学术研究联盟 (SHARC) 的科学专家小组</title><link/>https://pubmed.ncbi.nlm.nih.gov/37782695/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff =20231003060854&amp;v=2.17.9.post6+86293ac<description>休克学术研究联盟是一个多方利益相关者团体，包括来自美国食品和药物管理局以及其他政府机构、行业和付款人的代表，旨在制定实用的共识定义，有助于评估招募心源性休克患者的临床试验，包括评估机械循环支持装置的试验。2020 年至 2022 年期间召开了几次面对面和虚拟会议，讨论……的必要性。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>流通</b>. 2023 年 10 月 3 日；148(14):1113-1126. doi: 10.1161/CIRCULATIONAHA.123.064527. Epub 2023 年 10 月 2 日。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">休克学术研究联盟是一个多方利益相关者团体，包括来自美国食品和药物管理局以及其他政府机构、行业和付款人的代表，旨在制定实用的共识定义，有助于评估招募心源性休克患者的临床试验，包括评估机械循环支持装置的试验。2020 年至 2022 年期间召开了多次现场会议和虚拟会议，讨论是否需要制定评估心源性休克患者临床试验中的机械循环支持装置所需的标准化定义。专家小组确定通过进行文献综述（包括以前的临床试验）来了解关键概念和主题，同时认识到当前的挑战以及推进循证实践和统计分析以支持未来临床试验的必要性。对于每个类别，指定一位主要（主要）作者来执行文献检索并起草拟议的定义，并提交给小组。根据专家小组会议的反馈，对这些定义进行进一步修改，直至达成共识。本手稿总结了专家小组的建议，重点关注结果定义，包括功效和安全性。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37782695/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231003060854&v=2.17.9.post6+86293ac">37782695</a> | DOI： <a href=https://doi.org/10.1161/CIRCULATIONAHA.123.064527>10.1161/CIRCULATIONAHA.123.064527</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37782695</guid><pubDate> Mon, 02 Oct 2023 06:00:00 -0400</pubDate><dc:creator>罗恩·瓦克斯曼</dc:creator><dc:creator>莫希特·帕胡贾</dc:creator><dc:creator>肖恩·范·迪彭</dc:creator><dc:creator>阿拉斯泰尔·G·普劳德福特</dc:creator><dc:creator>大卫·莫罗</dc:creator><dc:creator>欧内斯特·斯皮策</dc:creator><dc:creator>格雷厄姆·尼科尔</dc:creator><dc:creator>迈伦·L·韦斯费尔特</dc:creator><dc:creator>莫罗·莫斯库奇</dc:creator><dc:creator>帕特里克·R·劳勒</dc:creator><dc:creator>亚历山大·梅巴扎</dc:creator><dc:creator>范艾迪</dc:creator><dc:creator>尼尔·W·迪克特</dc:creator><dc:creator>马克·萨姆斯基</dc:creator><dc:creator>罗伯特·科莫斯</dc:creator><dc:creator>伊莱安娜·L·皮纳</dc:creator><dc:creator>布拉姆·祖克曼</dc:creator><dc:creator>安德鲁·法布</dc:creator><dc:creator>约翰·S·萨皮斯坦</dc:creator><dc:creator>查尔斯·西蒙顿</dc:creator><dc:creator>尼克·EJ·韦斯特</dc:creator><dc:creator>阿卜杜拉·达姆鲁吉</dc:creator><dc:creator>伊恩·吉尔克里斯特</dc:creator><dc:creator>乌韦·泽梅尔</dc:creator><dc:creator>霍尔格·蒂勒</dc:creator><dc:creator>唐纳德·E·卡特利普</dc:creator><dc:creator>米切尔·克鲁科夫</dc:creator><dc:creator>威廉·T·亚伯拉罕</dc:creator><dc:date>2023-10-02</dc:date><dc:source>循环</dc:source><dc:title>心源性休克研究和机械循环支持装置的标准化定义：休克学术研究联盟 (SHARC) 的科学专家小组</dc:title><dc:identifier>下午:37782695</dc:identifier><dc:identifier> doi:10.1161/循环AHA.123.064527</dc:identifier></item><item><title> BRCC3 介导的 NLRP3 去泛素化促进 &lt;em>;Tet2&lt;/em>; 克隆造血中炎症小体激活和动脉粥样硬化</title><link/>https://pubmed.ncbi.nlm.nih.gov/37781816/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff =20231003060854&amp;v=2.17.9.post6+86293ac<description>结论：高胆固醇血症和 TET2 缺乏症集中在由 JNK1 激活和 BRCC3 介导的 NLRP3 去泛素化介导的 NLRP3 炎性体激活的共同途径上，对 TET2 CH 心血管疾病的预防具有潜在的治疗意义。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>流通</b>。2023 年 10 月 2 日。doi：10.1161/CIRCULATIONAHA.123.065344。印刷前在线。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">背景：克隆性造血（CH）已成为动脉粥样硬化性心血管疾病的独立危险因素，巨噬细胞炎症小体的激活是潜在的潜在机制。NLRP3（NLR家族含有pyrin结构域3）炎症小体在促进小鼠动脉粥样硬化中发挥着关键作用。 <i>Tet2</i> CH 模型，而在 CANTOS 中抑制炎症体产物白介素-1β 似乎对<i>TET2</i> CH 患者特别有益（心血管风险降低研究 [减少复发性主要心血管疾病事件]）。 <i>TET2</i>是一种表观遗传修饰剂，可减少启动子甲基化。然而，TET2（Tet 甲基胞嘧啶双加氧酶 2）缺陷时巨噬细胞 NLRP3 炎症小体激活的机制以及与表观遗传修饰的潜在联系尚不清楚。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：我们使用负载胆固醇的 TET2 缺陷型小鼠和胚胎干细胞来源的同基因人类巨噬细胞来评估体外 NLRP3 炎性小体激活的机制，并使用高胆固醇血症<i>Ldlr</i> <sup>- <i>/</i> -</sup>小鼠模拟<i>TET2</i> CH 来评估 NLRP3 炎性小体激活在动脉粥样硬化中的作用。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：小鼠巨噬细胞中的<i>Tet2</i>缺陷与细胞培养中的胆固醇负荷和体内高胆固醇血症协同作用，增加 JNK1（c-Jun N 端激酶 1）磷酸化和 NLRP3 炎性体激活。 <i>Dusp10</i>启动子甲基化的主动 Tet1-deadCas9 靶向编辑消除了<i>Tet2</i>缺陷型巨噬细胞中胆固醇诱导的炎症小体激活<i>。JNK1</i>信号传导增加导致 NLRP3 去泛素化并被去泛素化酶 BRCC3（含<i>BRCA1/BRCA2</i>的复合亚基 3）激活。加速动脉粥样硬化和<i>Tet2</i> CH 小鼠的中性粒细胞胞外陷阱形成 (NETosis) 可被 BRCC3 去泛素酶抑制剂全霉素以及 Abro1（含 BRCC3 的胞质复合物中的重要支架蛋白）的造血缺陷所逆转。人<i>TET2</i> <sup>- <i>/</i> -</sup>巨噬细胞表现出 JNK1 增加NLRP3 炎性体激活，尤其是在胆固醇负荷后，可通过全霉素治疗逆转，表明与人类相关。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：高胆固醇血症和 TET2 缺乏症集中在由 JNK1 激活和 BRCC3 介导的 NLRP3 去泛素化介导的 NLRP3 炎性体激活的共同途径上，对<i>TET2</i> CH 心血管疾病的预防具有潜在的治疗意义。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37781816/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231003060854&v=2.17.9.post6+86293ac">37781816</a> | DOI： <a href=https://doi.org/10.1161/CIRCULATIONAHA.123.065344>10.1161/CIRCULATIONAHA.123.065344</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37781816</guid><pubDate> Mon, 02 Oct 2023 06:00:00 -0400</pubDate><dc:creator>穆斯塔法·亚辛卡亚</dc:creator><dc:creator>刘文丽</dc:creator><dc:creator>利·安妮·托马斯</dc:creator><dc:creator>马尔戈扎塔·奥尔谢斯卡</dc:creator><dc:creator>童晓</dc:creator><dc:creator>桑德拉·阿布拉莫维奇</dc:creator><dc:creator>埃里尼·P·帕帕佩特鲁</dc:creator><dc:creator>马里特·韦斯特特普</dc:creator><dc:creator>王楠</dc:creator><dc:creator>伊拉·塔巴斯</dc:creator><dc:creator>艾伦·R·高尔</dc:creator><dc:date>2023-10-02</dc:date><dc:source>循环</dc:source><dc:title>BRCC3 介导的 NLRP3 去泛素化促进 &lt;em>;Tet2&lt;/em>; 克隆造血中炎症小体激活和动脉粥样硬化</dc:title><dc:identifier>下午：37781816</dc:identifier><dc:identifier> doi:10.1161/循环AHA.123.065344</dc:identifier></item><item><title>有症状的外周动脉疾病患者的心理健康负担、临床表现和结果之间的关联：美国心脏协会的科学声明</title><link/>https://pubmed.ncbi.nlm.nih.gov/37781785/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff =20231003060854&amp;v=2.17.9.post6+86293ac<description>随着外周动脉疾病 (PAD) 负担的不断增加，心理健康问题越来越被认为是有症状的 PAD 慢性疾病管理中需要解决的合并症。除了合并症心理健康状况的高患病率之外，疼痛和改变健康行为以及疾病的更广泛影响以及适应 PAD 生活需要专门的行为健康专业知识。这一科学陈述证明了这种专业知识...... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>流通</b>。2023 年 10 月 2 日。doi：10.1161/CIR.0000000000001178。印刷前在线。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">随着外周动脉疾病 (PAD) 负担的不断增加，心理健康问题越来越被认为是有症状的 PAD 慢性疾病管理中需要解决的合并症。除了合并症心理健康状况的高患病率之外，疼痛和改变健康行为以及疾病和适应 PAD 生活的更广泛影响需要专门的行为健康专业知识。这一科学陈述提出了一个案例，即这种专业知识应该整合到多学科 PAD 团队中。此外，认知功能障碍和姑息治疗等领域强调需要心理干预。尽管心理和精神治疗干预效果的许多证据都是从其他心血管人群推断出来的，但越来越多的证据表明心理干预对行为改变（例如，采取运动疗法）的作用讨论了行为健康需求领域以及与 PAD 治疗的相互作用，包括阿片类药物的使用、抑郁症管理、焦虑和压力减轻干预措施、苯二氮卓类药物和抗抑郁药的使用、戒烟、截肢后的康复轨迹以及PAD 治疗和结果的认知能力下降。案例摘要强调了围绕心理健康和血管疾病的耻辱以及护理的分散性。这份科学声明为建立综合行为 PAD 护理路线图和克服这些障碍的潜在解决方案提供了评论。为了实现这些变化，需要跨专业的宣传工作和举措，帮助打破心理健康的耻辱，促进基于证据的协作、非等级和多学科的 PAD 护理。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37781785/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231003060854&v=2.17.9.post6+86293ac">37781785</a> | DOI： <a href=https://doi.org/10.1161/CIR.0000000000001178>10.1161/CIR.0000000000001178</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37781785</guid><pubDate> Mon, 02 Oct 2023 06:00:00 -0400</pubDate><dc:creator>金·G·斯莫尔德伦</dc:creator><dc:creator>扎伊纳布·萨曼</dc:creator><dc:creator>卡罗尔·德克尔</dc:creator><dc:creator>特蕾西·柯林斯</dc:creator><dc:creator>罗纳德·M·拉扎尔</dc:creator><dc:creator>内森·K·伊托加</dc:creator><dc:creator>卡洛斯·梅纳·乌尔塔多</dc:creator><dc:creator>美国心脏协会周围血管疾病委员会；心血管和中风护理委员会；临床心脏病学委员会；生活方式和心脏代谢健康委员会；以及护理质量和结果研究委员会</dc:creator><dc:date>2023-10-02</dc:date><dc:source>循环</dc:source><dc:title>有症状的外周动脉疾病患者的心理健康负担、临床表现和结果之间的关联：美国心脏协会的科学声明</dc:title><dc:identifier>下午：37781785</dc:identifier><dc:identifier>号码：10.1161/CIR.0000000000001178</dc:identifier></item><item><title>关注心力衰竭和心肌病：新的 ESC 指南和关键荟萃分析</title><link/>https://pubmed.ncbi.nlm.nih.gov/37778030/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff =20231003060854&amp;v=2.17.9.post6+86293ac<description>无摘要</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> 《欧洲心脏杂志》2023 年 10 月 1 日；44(37):3487-3491.doi: 10.1093/eurheartj/ehad647。</p><p><b>无摘要</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37778030/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231003060854&v=2.17.9.post6+86293ac">37778030</a> | DOI： <a href=https://doi.org/10.1093/eurheartj/ehad647>10.1093/eurheartj/ehad647</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37778030</guid><pubDate> Sun, 01 Oct 2023 06:00:00 -0400</pubDate><dc:creator>菲利波·克雷亚</dc:creator><dc:date>2023-10-01</dc:date><dc:source>欧洲心脏杂志</dc:source><dc:title>关注心力衰竭和心肌病：新的 ESC 指南和关键荟萃分析</dc:title><dc:identifier>下午:37778030</dc:identifier><dc:identifier> doi:10.1093/eurheartj/ehad647</dc:identifier></item><item><title>了解 T2MI：感谢女性</title><link/>https://pubmed.ncbi.nlm.nih.gov/37777948/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff =20231003060854&amp;v=2.17.9.post6+86293ac<description>无摘要</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> J Am Coll Cardiol。2023 年 9 月 18 日：S0735-1097(23)06470-7。doi：10.1016/j.jacc.2023.08.021。印刷前在线。</p><p><b>无摘要</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37777948/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231003060854&v=2.17.9.post6+86293ac">37777948</a> | DOI： <a href=https://doi.org/10.1016/j.jacc.2023.08.021>10.1016/j.jacc.2023.08.021</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37777948</guid><pubDate> Sun, 01 Oct 2023 06:00:00 -0400</pubDate><dc:creator> C诺埃尔·贝雷·梅尔茨</dc:creator><dc:creator>玛莎·古拉蒂</dc:creator><dc:creator>魏珍妮</dc:creator><dc:date>2023-10-01</dc:date><dc:source>美国心脏病学会杂志</dc:source><dc:title>了解 T2MI：感谢女性</dc:title><dc:identifier>下午：37777948</dc:identifier><dc:identifier> doi:10.1016/j.jacc.2023.08.021</dc:identifier></item><item><title> 2 型心肌梗死患者的冠状动脉计算机断层扫描血管造影与血流储备分数</title><link/>https://pubmed.ncbi.nlm.nih.gov/37777947/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff =20231003060854&amp;v=2.17.9.post6+86293ac<description>结论：在判定为 T2MI 的个体中，CAD 很常见，但大多数患者患有非阻塞性 CAD。该人群中缺血的介质可能是多因素的。（使用 CT 定义 2 型心肌梗死患者中冠状动脉疾病的患病率和特征） -FFR [定义类型 2 MI]；NCT04864119）。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> J Am Coll Cardiol。2023 年 9 月 18 日：S0735-1097(23)06469-0。doi：10.1016/j.jacc.2023.08.020。印刷前在线。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">背景：与冠状动脉血流供需失衡相关的 2 型心肌梗死 (T2MI) 很常见，且预后不良。冠状动脉疾病 (CAD) 可能使某些个体易患 T2MI，并导致心血管事件复发率较高. 对于该人群中 CAD 的存在及其程度知之甚少。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">目的：本研究的目的是评估 T2MI 患者中 CAD 的存在情况和特征。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：在这项前瞻性研究中，连续纳入符合第四版心肌梗死通用定义 T2MI 标准的合格个体。参与者接受了冠状动脉计算机断层扫描血管造影 (CTA)、冠状动脉 CTA 得出的血流储备分数 (FFR <sub>CT</sub> ) 和斑块体积分析。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：50 名参与者中，25 名（50%）为女性，平均年龄为 68.0 ± 11.4 岁。动脉粥样硬化危险因素很常见。冠状动脉 CTA 显示 46 名参与者（92%）有冠状动脉斑块。中度或以上狭窄（≥ 42% 的参与者发现了阻塞性疾病（左主干狭窄≥50%，或任何其他心外膜冠状动脉狭窄≥70%），26% 的参与者存在阻塞性疾病。阻塞性 CAD 的患病率并没有根据 T2MI 原因而存在差异。 (P = 0.54)。13 名参与者 (26%) 存在由 FFR <sub>CT</sub>识别出的血流动力学显着狭窄。在狭窄 ≥50% (n = 21) 的参与者中，FFR <sub>CT</sub>排除了 8 名患者的病变特异性血流动力学显着狭窄。例（38%）。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：在判定为 T2MI 的个体中，CAD 很常见，但大多数患者患有非阻塞性 CAD。该人群中缺血的介质可能是多因素的。（使用 CT 定义 2 型心肌梗死患者中冠状动脉疾病的患病率和特征） -FFR [定义类型 2 MI]；NCT04864119）。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37777947/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231003060854&v=2.17.9.post6+86293ac">37777947</a> | DOI： <a href=https://doi.org/10.1016/j.jacc.2023.08.020>10.1016/j.jacc.2023.08.020</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37777947</guid><pubDate> Sun, 01 Oct 2023 06:00:00 -0400</pubDate><dc:creator>西安·P·麦卡锡</dc:creator><dc:creator>肖恩·P·墨菲</dc:creator><dc:creator>丹尼尔·K·安蓬萨</dc:creator><dc:creator>保拉·兰巴拉特</dc:creator><dc:creator>林嘉儿</dc:creator><dc:creator>刘玉玺</dc:creator><dc:creator>礼萨·莫赫比</dc:creator><dc:creator>艾莉森·莱文</dc:creator><dc:creator>阿凡蒂·拉格万</dc:creator><dc:creator>汉娜·米克塞纳斯</dc:creator><dc:creator>坎贝尔·罗杰斯</dc:creator><dc:creator>杰森·H·瓦斯菲</dc:creator><dc:creator>罗恩·布兰克斯坦</dc:creator><dc:creator>布赖恩·戈什哈吉拉</dc:creator><dc:creator>桑迪普树篱</dc:creator><dc:creator>詹姆斯·贾努齐</dc:creator><dc:date>2023-10-01</dc:date><dc:source>美国心脏病学会杂志</dc:source><dc:title>2 型心肌梗死患者的冠状动脉计算机断层扫描血管造影与血流储备分数</dc:title><dc:identifier>下午：37777947</dc:identifier><dc:identifier> doi:10.1016/j.jacc.2023.08.020</dc:identifier></item><item><title>基于 AsCas12f 的紧凑型基因组编辑工具，由深度突变扫描和结构分析衍生而来</title><link/>https://pubmed.ncbi.nlm.nih.gov/37776859/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff =20231003060854&amp;v=2.17.9.post6+86293ac<description> SpCas9 和 AsCas12a 被广泛用作人类细胞中的基因组编辑工具。然而，它们相对较大的尺寸对限制货物尺寸的腺相关病毒 (AAV) 载体的递送造成了限制。来自 Acidibacillus sulfogenics 的 VF Cas12f 型是例外紧凑（422 个氨基酸），并已被用作紧凑的基因组编辑工具。在这里，我们开发了一种方法，结合深度突变扫描和结构知情设计，成功生成两个 AsCas12f... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Cell</b> . 2023 年 9 月 22 日：S0092-8674(23)00963-7. doi: 10.1016/j.cell.2023.08.031. 印刷前在线。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> SpCas9 和 AsCas12a 被广泛用作人类细胞中的基因组编辑工具。然而，它们相对较大的尺寸对限制货物尺寸的腺相关病毒 (AAV) 载体的递送造成了限制。来自 Acidibacillus sulfogenics 的 VF Cas12f 型是例外紧凑（422 个氨基酸），并已被用作紧凑的基因组编辑工具。在这里，我们开发了一种方法，结合深度突变扫描和结构知情设计，成功生成两个 AsCas12f 活性增强 (enAsCas12f) 变体。值得注意的是， enAsCas12f 在人类细胞中显示出与 SpCas9 和 AsCas12a 变体相当的基因组编辑活性。冷冻电子显微镜 (cryo-EM) 结构显示，这些突变稳定了二聚体的形成并加强了与核酸的相互作用，从而增强了其 DNA 切割活性。总之，enAsCas12f 变体可以为体内基因治疗提供最小的基因组编辑平台。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37776859/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231003060854&v=2.17.9.post6+86293ac">37776859</a> | DOI： <a href=https://doi.org/10.1016/j.cell.2023.08.031>10.1016/j.cell.2023.08.031</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37776859</guid><pubDate> Sat, 30 Sep 2023 06:00:00 -0400</pubDate><dc:creator>日野智宏</dc:creator><dc:creator>大村聪</dc:creator><dc:creator>中川亮也</dc:creator><dc:creator>富坚智树</dc:creator><dc:creator>武田悟</dc:creator><dc:creator>平本贵文</dc:creator><dc:creator>田坂聪</dc:creator><dc:creator>平野久里</dc:creator><dc:creator>德山武</dc:creator><dc:creator>鱼崎英树</dc:creator><dc:creator>石黑壮</dc:creator><dc:creator>麦迪娜·卡吉耶娃</dc:creator><dc:creator>山野弘之</dc:creator><dc:creator>尾崎由纪</dc:creator><dc:creator>本冈大辅</dc:creator><dc:creator>森英人</dc:creator><dc:creator>桐田佑平</dc:creator><dc:creator>黄濑义明</dc:creator><dc:creator>伊藤雄</dc:creator><dc:creator>场里明</dc:creator><dc:creator>油谷宏之</dc:creator><dc:creator>谷智望</dc:creator><dc:creator>陶特维达斯·卡维利斯</dc:creator><dc:creator>维尔尼吉斯·西克斯尼斯</dc:creator><dc:creator>大森司</dc:creator><dc:creator>星野敦</dc:creator><dc:creator>努雷木修</dc:creator><dc:date>2023-09-30</dc:date><dc:source>细胞</dc:source><dc:title>基于 AsCas12f 的紧凑型基因组编辑工具，由深度突变扫描和结构分析衍生而来</dc:title><dc:identifier>下午:37776859</dc:identifier><dc:identifier> doi:10.1016/j.cell.2023.08.031</dc:identifier></item><item><title>出生后对 SARS-CoV-2 粘膜和全身免疫的多组学分析</title><link/>https://pubmed.ncbi.nlm.nih.gov/37776858/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff =20231003060854&amp;v=2.17.9.post6+86293ac<description>婴儿对感染的免疫力动态仍不清楚。在这里，我们采用多组学方法，通过分析婴儿和幼儿的血液样本，对婴幼儿对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的免疫力进行纵向分析以及每周在感染 Omicron 和非 Omicron 变体之前、期间和之后收集的鼻拭子。感染刺激了强大的抗体滴度，与成人不同，这种滴度在长达 300 天内没有显示出衰减的迹象。婴儿... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Cell</b> . 2023 年 9 月 26 日：S0092-8674(23)00978-9. doi: 10.1016/j.cell.2023.08.044. 印刷前在线。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">婴儿对感染的免疫力动态仍不清楚。在这里，我们采用多组学方法，通过分析婴儿和幼儿的血液样本，对婴幼儿对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的免疫力进行纵向分析以及每周在感染 Omicron 和非 Omicron 变体之前、期间和之后收集的鼻拭子。感染刺激了强大的抗体滴度，与成人不同，该滴度在长达 300 天内没有显示出衰减的迹象。婴儿产生了强大的粘膜免疫反应，其特征是炎症细胞因子、干扰素 (IFN) α 和 T 辅助细胞 (Th) 17 以及中性粒细胞标记物（白细胞介素 [IL]-17、IL-8 和 CXCL1）。血液中的免疫反应的特点是先天激活标记物上调。细胞，没有炎症细胞因子，但有几种趋化因子和 IFNα。后者与通过单细胞多组学测量的骨髓细胞中病毒载量和干扰素刺激基因 (ISG) 的表达相关。总而言之，这些数据提供了免疫的快照在生命的最初几周和几个月内感染。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37776858/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231003060854&v=2.17.9.post6+86293ac">37776858</a> | DOI： <a href=https://doi.org/10.1016/j.cell.2023.08.044>10.1016/j.cell.2023.08.044</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37776858</guid><pubDate> Sat, 30 Sep 2023 06:00:00 -0400</pubDate><dc:creator>弗洛里安·威默斯</dc:creator><dc:creator>艾莉森·R·伯勒尔</dc:creator><dc:creator>冯玉鹏</dc:creator><dc:creator>郑洪</dc:creator><dc:creator>帕布·阿鲁纳查兰</dc:creator><dc:creator>胡梦云</dc:creator><dc:creator>萨拉·斯普兰格</dc:creator><dc:creator>林赛·E·尼霍夫</dc:creator><dc:creator>德维亚尼·乔希</dc:creator><dc:creator>米拉·特萨尔</dc:creator><dc:creator>玛扬卡·阿瓦斯提</dc:creator><dc:creator>洛伦扎·贝鲁西</dc:creator><dc:creator>乌萨马·阿什拉夫</dc:creator><dc:creator>桑吉塔·科利</dc:creator><dc:creator>凯瑟琳·康文斯</dc:creator><dc:creator>杨艾米莉</dc:creator><dc:creator>迈克尔·布兰科</dc:creator><dc:creator>凯瑟琳·佩莱格里尼</dc:creator><dc:creator>格雷戈里·撒普</dc:creator><dc:creator>托马斯·哈根</dc:creator><dc:creator>R莎伦·钦特拉贾</dc:creator><dc:creator>陈T阮</dc:creator><dc:creator>阿尔巴·格里福尼</dc:creator><dc:creator>亚历山德罗·塞特</dc:creator><dc:creator>卡里·C·纳多</dc:creator><dc:creator>大卫·B·哈斯拉姆</dc:creator><dc:creator>史蒂文·E·博辛格</dc:creator><dc:creator>延斯·瓦默特</dc:creator><dc:creator>霍尔顿·T·梅克</dc:creator><dc:creator>保罗·尤茨</dc:creator><dc:creator>王泰亚</dc:creator><dc:creator>投降库拉纳</dc:creator><dc:creator>普韦什·卡特里</dc:creator><dc:creator>玛丽·斯塔特</dc:creator><dc:creator>巴厘岛普伦德兰</dc:creator><dc:date>2023-09-30</dc:date><dc:source>细胞</dc:source><dc:title>出生后对 SARS-CoV-2 粘膜和全身免疫的多组学分析</dc:title><dc:identifier>下午:37776858</dc:identifier><dc:identifier> doi:10.1016/j.cell.2023.08.044</dc:identifier></item><item><title> MINOCA 中的性别和种族差异</title><link/>https://pubmed.ncbi.nlm.nih.gov/37775559/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff =20231003060854&amp;v=2.17.9.post6+86293ac<description>疑似非梗阻性冠状动脉心肌梗死 (MINOCA) 在过去十年中受到越来越多的关注。考虑到不存在梗阻性冠状动脉的急性心肌梗死机制的异质性，MINOCA 综合征被认为是一种可行的诊断，需要进行诊断。进行诊断性血管造影研究后进行进一步调查，包括冠状动脉磁共振血管造影和功能性血管造影...... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Nat Rev Cardiol。2023 年 9 月 29 日。doi：10.1038/s41569-023-00927-6。印刷前在线。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">疑似非梗阻性冠状动脉心肌梗死 (MINOCA) 在过去十年中受到越来越多的关注。考虑到不存在梗阻性冠状动脉的急性心肌梗死机制的异质性，MINOCA 综合征被认为是一种可行的诊断，需要进行诊断。尽管一度被认为是一种罕见且低风险的心肌梗死形式，但最近的数据表明，MINOCA 的预后并不像以前假设的那样良性。然而，尽管人们对该病的认识不断提高，但关于 MINOCA 的诊断、风险分层和治疗仍然存在许多问题。女性似乎同样容易患 MINOCA，但关于该疾病的性别差异的研究很少。这些因素可能解释了 MINOCA 观察到的患病率或潜在病理生理机制的差异，但数据也很少。因此，在本综述中，我们提供了有关临床特征中性别特异性和种族特异性差异的最新证据的更新， MINOCA 的病理生理机制、治疗和预后。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37775559/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231003060854&v=2.17.9.post6+86293ac">37775559</a> | DOI： <a href=https://doi.org/10.1038/s41569-023-00927-6>10.1038/s41569-023-00927-6</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37775559</guid><pubDate> Fri, 29 Sep 2023 06:00:00 -0400</pubDate><dc:creator>萨雷娜·拉</dc:creator><dc:creator>约翰·贝尔特拉姆</dc:creator><dc:creator>罗莎娜·塔维拉</dc:creator><dc:date>2023-09-29</dc:date><dc:source> 《自然》评论、心脏病学</dc:source><dc:title>MINOCA 中的性别和种族差异</dc:title><dc:identifier>下午:37775559</dc:identifier><dc:identifier> doi:10.1038/s41569-023-00927-6</dc:identifier></item><item><title>合成 Par 极性诱导未极化哺乳动物细胞的细胞骨架不对称</title><link/>https://pubmed.ncbi.nlm.nih.gov/37774705/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff =20231003060854&amp;v=2.17.9.post6+86293ac<description>极化细胞依赖于极化的细胞骨架来发挥作用。然而，皮质极性线索如何诱导细胞骨架极化仍然是难以捉摸的。在这里，我们利用最近建立的设计的二维蛋白质阵列来异位改造几乎任何感兴趣的蛋白质在各种细胞类型的有丝分裂过程中的皮质极性。这使得能够直接操纵极性信号传导并识别足以细胞骨架极化的皮质线索。使用这种测定，我们... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Cell</b> . 2023 年 9 月 20 日：S0092-8674(23)00968-6. doi: 10.1016/j.cell.2023.08.034. 印刷前在线。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">极化细胞依赖于极化的细胞骨架来发挥作用。然而，皮质极性线索如何诱导细胞骨架极化仍然是难以捉摸的。在这里，我们利用最近建立的设计的二维蛋白质阵列来异位改造几乎任何感兴趣的蛋白质在各种细胞类型的有丝分裂过程中的皮质极性这使得能够直接操纵极性信号传导并识别足以进行细胞骨架极化的皮质线索。使用这种测定，我们剖析了 Par 复合体途径的逻辑，Par 复合体途径是不对称细胞分裂期间细胞骨架极性的关键调节因子。我们表明，任何 Par 复合体亚基都足以触发复合体组装，并且复合体组装的主要动力学障碍是 Par6 自抑制的缓解。此外，我们发现诱导皮质 Par 复合体极性会诱导非极化哺乳动物细胞中不对称细胞分裂的两个标志：纺锤体方向，通过 Par3 和中心纺锤体不对称发生，具体取决于 aPKC 活性。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37774705/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231003060854&v=2.17.9.post6+86293ac">37774705</a> | DOI： <a href=https://doi.org/10.1016/j.cell.2023.08.034>10.1016/j.cell.2023.08.034</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37774705</guid><pubDate> Fri, 29 Sep 2023 06:00:00 -0400</pubDate><dc:creator>约瑟夫·沃森</dc:creator><dc:creator>拉拉·K·克鲁格</dc:creator><dc:creator>阿里尔·J·本-萨森</dc:creator><dc:creator>艾丽丝·比特斯顿</dc:creator><dc:creator>玛尔塔·N·沙巴齐</dc:creator><dc:creator>维森特·何塞·普拉内勒斯-埃雷罗</dc:creator><dc:creator>约瑟夫·E·钱伯斯</dc:creator><dc:creator>詹姆斯·D·曼顿</dc:creator><dc:creator>大卫·贝克</dc:creator><dc:creator>伊曼纽尔交付</dc:creator><dc:date>2023-09-29</dc:date><dc:source>细胞</dc:source><dc:title>合成 Par 极性诱导未极化哺乳动物细胞的细胞骨架不对称</dc:title><dc:identifier>下午:37774705</dc:identifier><dc:identifier> doi:10.1016/j.cell.2023.08.034</dc:identifier></item><item><title> A widely distributed gene cluster compensates for uricase loss in hominids</title><link/> https://pubmed.ncbi.nlm.nih.gov/37774682/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231003060854&amp;v=2.17.9.post6+86293ac<description> No abstract </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Cell</b> . 2023 Sep 28;186(20):4472-4473. doi: 10.1016/j.cell.2023.08.036.</p><p> <b>NO ABSTRACT</b></p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37774682/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231003060854&v=2.17.9.post6+86293ac">37774682</a> | DOI: <a href=https://doi.org/10.1016/j.cell.2023.08.036>10.1016/j.cell.2023.08.036</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:37774682</guid><pubDate> Fri, 29 Sep 2023 06:00:00 -0400</pubDate><dc:creator> Yuanyuan Liu</dc:creator><dc:creator> J Bryce Jarman</dc:creator><dc:creator> Yen S Low</dc:creator><dc:creator> Hannah E Augustijn</dc:creator><dc:creator> Steven Huang</dc:creator><dc:creator> Haoqing Chen</dc:creator><dc:creator> Mary E DeFeo</dc:creator><dc:creator> Kazuma Sekiba</dc:creator><dc:creator> Bi-Huei Hou</dc:creator><dc:creator> Xiandong Meng</dc:creator><dc:creator> Allison M Weakley</dc:creator><dc:creator> Ashley V Cabrera</dc:creator><dc:creator> Zhiwei Zhou</dc:creator><dc:creator> Gilles van Wezel</dc:creator><dc:creator> Marnix H Medema</dc:creator><dc:creator> Calyani Ganesan</dc:creator><dc:creator> Alan C Pao</dc:creator><dc:creator> Saurabh Gombar</dc:creator><dc:creator> Dylan Dodd</dc:creator><dc:date> 2023-09-29</dc:date><dc:source> Cell</dc:source><dc:title> A widely distributed gene cluster compensates for uricase loss in hominids</dc:title><dc:identifier> pmid:37774682</dc:identifier><dc:identifier> doi:10.1016/j.cell.2023.08.036</dc:identifier></item><item><title> Early Alzheimer&#39;s disease pathology in human cortex involves transient cell states</title><link/> https://pubmed.ncbi.nlm.nih.gov/37774681/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231003060854&amp;v=2.17.9.post6+86293ac<description> Cellular perturbations underlying Alzheimer&#39;s disease (AD) are primarily studied in human postmortem samples and model organisms. Here, we generated a single-nucleus atlas from a rare cohort of cortical biopsies from living individuals with varying degrees of AD pathology. We next performed a systematic cross-disease and cross-species integrative analysis to identify a set of cell states that are specific to early AD pathology. These changes-which we refer to as the early cortical amyloid... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Cell</b> . 2023 Sep 28;186(20):4438-4453.e23. doi: 10.1016/j.cell.2023.08.005.</p><p> <b>ABSTRACT</b> </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> Cellular perturbations underlying Alzheimer&#39;s disease (AD) are primarily studied in human postmortem samples and model organisms. Here, we generated a single-nucleus atlas from a rare cohort of cortical biopsies from living individuals with varying degrees of AD pathology. We next performed a systematic cross-disease and cross-species integrative analysis to identify a set of cell states that are specific to early AD pathology. These changes-which we refer to as the early cortical amyloid response-were prominent in neurons, wherein we identified a transitional hyperactive state preceding the loss of excitatory neurons, which we confirmed by acute slice physiology on independent biopsy specimens. Microglia overexpressing neuroinflammatory-related processes also expanded as AD pathology increased. Finally, both oligodendrocytes and pyramidal neurons upregulated genes associated with β-amyloid production and processing during this early hyperactive phase. Our integrative analysis provides an organizing framework for targeting circuit dysfunction, neuroinflammation, and amyloid production early in AD pathogenesis.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37774681/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231003060854&v=2.17.9.post6+86293ac">37774681</a> | DOI: <a href=https://doi.org/10.1016/j.cell.2023.08.005>10.1016/j.cell.2023.08.005</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:37774681</guid><pubDate> Fri, 29 Sep 2023 06:00:00 -0400</pubDate><dc:creator> Vahid Gazestani</dc:creator><dc:creator> Tushar Kamath</dc:creator><dc:creator> Naeem M Nadaf</dc:creator><dc:creator> Antonios Dougalis</dc:creator><dc:creator> SJ Burris</dc:creator><dc:creator> Brendan Rooney</dc:creator><dc:creator> Antti Junkkari</dc:creator><dc:creator> Charles Vanderburg</dc:creator><dc:creator> Anssi Pelkonen</dc:creator><dc:creator> Mireia Gomez-Budia</dc:creator><dc:creator> Nelli-Noora Välimäki</dc:creator><dc:creator> Tuomas Rauramaa</dc:creator><dc:creator> Martine Therrien</dc:creator><dc:creator> Anne M Koivisto</dc:creator><dc:creator> Matthew Tegtmeyer</dc:creator><dc:creator> Sanna-Kaisa Herukka</dc:creator><dc:creator> Abdulraouf Abdulraouf</dc:creator><dc:creator> Samuel E Marsh</dc:creator><dc:creator> Mikko Hiltunen</dc:creator><dc:creator> Ralda Nehme</dc:creator><dc:creator> Tarja Malm</dc:creator><dc:creator> Beth Stevens</dc:creator><dc:creator> Ville Leinonen</dc:creator><dc:creator> Evan Z Macosko</dc:creator><dc:date> 2023-09-29</dc:date><dc:source> Cell</dc:source><dc:title> Early Alzheimer&#39;s disease pathology in human cortex involves transient cell states</dc:title><dc:identifier> pmid:37774681</dc:identifier><dc:identifier> doi:10.1016/j.cell.2023.08.005</dc:identifier></item><item><title> Epigenomic dissection of Alzheimer&#39;s disease pinpoints causal variants and reveals epigenome erosion</title><link/> https://pubmed.ncbi.nlm.nih.gov/37774680/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231003060854&amp;v=2.17.9.post6+86293ac<description> Recent work has identified dozens of non-coding loci for Alzheimer&#39;s disease (AD) risk, but their mechanisms and AD transcriptional regulatory circuitry are poorly understood. Here, we profile epigenomic and transcriptomic landscapes of 850,000 nuclei from prefrontal cortexes of 92 individuals with and without AD to build a map of the brain regulome, including epigenomic profiles, transcriptional regulators, co-accessibility modules, and peak-to-gene links in a cell-type-specific manner. We... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Cell</b> . 2023 Sep 28;186(20):4422-4437.e21. doi: 10.1016/j.cell.2023.08.040.</p><p> <b>ABSTRACT</b> </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> Recent work has identified dozens of non-coding loci for Alzheimer&#39;s disease (AD) risk, but their mechanisms and AD transcriptional regulatory circuitry are poorly understood. Here, we profile epigenomic and transcriptomic landscapes of 850,000 nuclei from prefrontal cortexes of 92 individuals with and without AD to build a map of the brain regulome, including epigenomic profiles, transcriptional regulators, co-accessibility modules, and peak-to-gene links in a cell-type-specific manner. We develop methods for multimodal integration and detecting regulatory modules using peak-to-gene linking. We show AD risk loci are enriched in microglial enhancers and for specific TFs including SPI1, ELF2, and RUNX1. We detect 9,628 cell-type-specific ATAC-QTL loci, which we integrate alongside peak-to-gene links to prioritize AD variant regulatory circuits. We report differential accessibility of regulatory modules in late AD in glia and in early AD in neurons. Strikingly, late-stage AD brains show global epigenome dysregulation indicative of epigenome erosion and cell identity loss.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37774680/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231003060854&v=2.17.9.post6+86293ac">37774680</a> | DOI: <a href=https://doi.org/10.1016/j.cell.2023.08.040>10.1016/j.cell.2023.08.040</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:37774680</guid><pubDate> Fri, 29 Sep 2023 06:00:00 -0400</pubDate><dc:creator> Xushen Xiong</dc:creator><dc:creator> Benjamin T James</dc:creator><dc:creator> Carles A Boix</dc:creator><dc:creator> Yongjin P Park</dc:creator><dc:creator> Kyriaki Galani</dc:creator><dc:creator> Matheus B Victor</dc:creator><dc:creator> Na Sun</dc:creator><dc:creator> Lei Hou</dc:creator><dc:creator> Li-Lun Ho</dc:creator><dc:creator> Julio Mantero</dc:creator><dc:creator> Aine Ni Scannail</dc:creator><dc:creator> Vishnu Dileep</dc:creator><dc:creator> Weixiu Dong</dc:creator><dc:creator> Hansruedi Mathys</dc:creator><dc:creator> David A Bennett</dc:creator><dc:creator> Li-Huei Tsai</dc:creator><dc:creator> Manolis Kellis</dc:creator><dc:date> 2023-09-29</dc:date><dc:source> Cell</dc:source><dc:title> Epigenomic dissection of Alzheimer&#39;s disease pinpoints causal variants and reveals epigenome erosion</dc:title><dc:identifier> pmid:37774680</dc:identifier><dc:identifier> doi:10.1016/j.cell.2023.08.040</dc:identifier></item><item><title> Neuronal DNA double-strand breaks lead to genome structural variations and 3D genome disruption in neurodegeneration</title><link/> https://pubmed.ncbi.nlm.nih.gov/37774679/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231003060854&amp;v=2.17.9.post6+86293ac<description> Persistent DNA double-strand breaks (DSBs) in neurons are an early pathological hallmark of neurodegenerative diseases including Alzheimer&#39;s disease (AD), with the potential to disrupt genome integrity. We used single-nucleus RNA-seq in human postmortem prefrontal cortex samples and found that excitatory neurons in AD were enriched for somatic mosaic gene fusions. Gene fusions were particularly enriched in excitatory neurons with DNA damage repair and senescence gene signatures. In addition,... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Cell</b> . 2023 Sep 28;186(20):4404-4421.e20. doi: 10.1016/j.cell.2023.08.038.</p><p> <b>ABSTRACT</b> </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> Persistent DNA double-strand breaks (DSBs) in neurons are an early pathological hallmark of neurodegenerative diseases including Alzheimer&#39;s disease (AD), with the potential to disrupt genome integrity. We used single-nucleus RNA-seq in human postmortem prefrontal cortex samples and found that excitatory neurons in AD were enriched for somatic mosaic gene fusions. Gene fusions were particularly enriched in excitatory neurons with DNA damage repair and senescence gene signatures. In addition, somatic genome structural variations and gene fusions were enriched in neurons burdened with DSBs in the CK-p25 mouse model of neurodegeneration. Neurons enriched for DSBs also had elevated levels of cohesin along with progressive multiscale disruption of the 3D genome organization aligned with transcriptional changes in synaptic, neuronal development, and histone genes. Overall, this study demonstrates the disruption of genome stability and the 3D genome organization by DSBs in neurons as pathological steps in the progression of neurodegenerative diseases.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37774679/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231003060854&v=2.17.9.post6+86293ac">37774679</a> | DOI: <a href=https://doi.org/10.1016/j.cell.2023.08.038>10.1016/j.cell.2023.08.038</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:37774679</guid><pubDate> Fri, 29 Sep 2023 06:00:00 -0400</pubDate><dc:creator> Vishnu Dileep</dc:creator><dc:creator> Carles A Boix</dc:creator><dc:creator> Hansruedi Mathys</dc:creator><dc:creator> Asaf Marco</dc:creator><dc:creator> Gwyneth M Welch</dc:creator><dc:creator> Hiruy S Meharena</dc:creator><dc:creator> Anjanet Loon</dc:creator><dc:creator> Ritika Jeloka</dc:creator><dc:creator> Zhuyu Peng</dc:creator><dc:creator> David A Bennett</dc:creator><dc:creator> Manolis Kellis</dc:creator><dc:creator> Li-Huei Tsai</dc:creator><dc:date> 2023-09-29</dc:date><dc:source> Cell</dc:source><dc:title> Neuronal DNA double-strand breaks lead to genome structural variations and 3D genome disruption in neurodegeneration</dc:title><dc:identifier> pmid:37774679</dc:identifier><dc:identifier> doi:10.1016/j.cell.2023.08.038</dc:identifier></item><item><title> Human microglial state dynamics in Alzheimer&#39;s disease progression</title><link/> https://pubmed.ncbi.nlm.nih.gov/37774678/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231003060854&amp;v=2.17.9.post6+86293ac<description> Altered microglial states affect neuroinflammation, neurodegeneration, and disease but remain poorly understood. Here, we report 194,000 single-nucleus microglial transcriptomes and epigenomes across 443 human subjects and diverse Alzheimer&#39;s disease (AD) pathological phenotypes. We annotate 12 microglial transcriptional states, including AD-dysregulated homeostatic, inflammatory, and lipid-processing states. We identify 1,542 AD-differentially-expressed genes, including both... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Cell</b> . 2023 Sep 28;186(20):4386-4403.e29. doi: 10.1016/j.cell.2023.08.037.</p><p> <b>ABSTRACT</b> </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> Altered microglial states affect neuroinflammation, neurodegeneration, and disease but remain poorly understood. Here, we report 194,000 single-nucleus microglial transcriptomes and epigenomes across 443 human subjects and diverse Alzheimer&#39;s disease (AD) pathological phenotypes. We annotate 12 microglial transcriptional states, including AD-dysregulated homeostatic, inflammatory, and lipid-processing states. We identify 1,542 AD-differentially-expressed genes, including both microglia-state-specific and disease-stage-specific alterations. By integrating epigenomic, transcriptomic, and motif information, we infer upstream regulators of microglial cell states, gene-regulatory networks, enhancer-gene links, and transcription-factor-driven microglial state transitions. We demonstrate that ectopic expression of our predicted homeostatic-state activators induces homeostatic features in human iPSC-derived microglia-like cells, while inhibiting activators of inflammation can block inflammatory progression. Lastly, we pinpoint the expression of AD-risk genes in microglial states and differential expression of AD-risk genes and their regulators during AD progression. Overall, we provide insights underlying microglial states, including state-specific and AD-stage-specific microglial alterations at unprecedented resolution.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37774678/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231003060854&v=2.17.9.post6+86293ac">37774678</a> | DOI: <a href=https://doi.org/10.1016/j.cell.2023.08.037>10.1016/j.cell.2023.08.037</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:37774678</guid><pubDate> Fri, 29 Sep 2023 06:00:00 -0400</pubDate><dc:creator> Na Sun</dc:creator><dc:creator> Matheus B Victor</dc:creator><dc:creator> Yongjin P Park</dc:creator><dc:creator> Xushen Xiong</dc:creator><dc:creator> Aine Ni Scannail</dc:creator><dc:creator> Noelle Leary</dc:creator><dc:creator> Shaniah Prosper</dc:creator><dc:creator> Soujanya Viswanathan</dc:creator><dc:creator> Xochitl Luna</dc:creator><dc:creator> Carles A Boix</dc:creator><dc:creator> Benjamin T James</dc:creator><dc:creator> Yosuke Tanigawa</dc:creator><dc:creator> Kyriaki Galani</dc:creator><dc:creator> Hansruedi Mathys</dc:creator><dc:creator> Xueqiao Jiang</dc:creator><dc:creator> Ayesha P Ng</dc:creator><dc:creator> David A Bennett</dc:creator><dc:creator> Li-Huei Tsai</dc:creator><dc:creator> Manolis Kellis</dc:creator><dc:date> 2023-09-29</dc:date><dc:source> Cell</dc:source><dc:title> Human microglial state dynamics in Alzheimer&#39;s disease progression</dc:title><dc:identifier> pmid:37774678</dc:identifier><dc:identifier> doi:10.1016/j.cell.2023.08.037</dc:identifier></item><item><title> Single-cell atlas reveals correlates of high cognitive function, dementia, and resilience to Alzheimer&#39;s disease pathology</title><link/> https://pubmed.ncbi.nlm.nih.gov/37774677/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231003060854&amp;v=2.17.9.post6+86293ac<description> Alzheimer&#39;s disease (AD) is the most common cause of dementia worldwide, but the molecular and cellular mechanisms underlying cognitive impairment remain poorly understood. To address this, we generated a single-cell transcriptomic atlas of the aged human prefrontal cortex covering 2.3 million cells from postmortem human brain samples of 427 individuals with varying degrees of AD pathology and cognitive impairment. Our analyses identified AD-pathology-associated alterations shared between... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Cell</b> . 2023 Sep 28;186(20):4365-4385.e27. doi: 10.1016/j.cell.2023.08.039.</p><p> <b>ABSTRACT</b> </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> Alzheimer&#39;s disease (AD) is the most common cause of dementia worldwide, but the molecular and cellular mechanisms underlying cognitive impairment remain poorly understood. To address this, we generated a single-cell transcriptomic atlas of the aged human prefrontal cortex covering 2.3 million cells from postmortem human brain samples of 427 individuals with varying degrees of AD pathology and cognitive impairment. Our analyses identified AD-pathology-associated alterations shared between excitatory neuron subtypes, revealed a coordinated increase of the cohesin complex and DNA damage response factors in excitatory neurons and in oligodendrocytes, and uncovered genes and pathways associated with high cognitive function, dementia, and resilience to AD pathology. Furthermore, we identified selectively vulnerable somatostatin inhibitory neuron subtypes depleted in AD, discovered two distinct groups of inhibitory neurons that were more abundant in individuals with preserved high cognitive function late in life, and uncovered a link between inhibitory neurons and resilience to AD pathology.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37774677/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231003060854&v=2.17.9.post6+86293ac">37774677</a> | DOI: <a href=https://doi.org/10.1016/j.cell.2023.08.039>10.1016/j.cell.2023.08.039</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:37774677</guid><pubDate> Fri, 29 Sep 2023 06:00:00 -0400</pubDate><dc:creator> Hansruedi Mathys</dc:creator><dc:creator> Zhuyu Peng</dc:creator><dc:creator> Carles A Boix</dc:creator><dc:creator> Matheus B Victor</dc:creator><dc:creator> Noelle Leary</dc:creator><dc:creator> Sudhagar Babu</dc:creator><dc:creator> Ghada Abdelhady</dc:creator><dc:creator> Xueqiao Jiang</dc:creator><dc:creator> Ayesha P Ng</dc:creator><dc:creator> Kimia Ghafari</dc:creator><dc:creator> Alexander K Kunisky</dc:creator><dc:creator> Julio Mantero</dc:creator><dc:creator> Kyriaki Galani</dc:creator><dc:creator> Vanshika N Lohia</dc:creator><dc:creator> Gabrielle E Fortier</dc:creator><dc:creator> Yasmine Lotfi</dc:creator><dc:creator> Jason Ivey</dc:creator><dc:creator> Hannah P Brown</dc:creator><dc:creator> Pratham R Patel</dc:creator><dc:creator> Nehal Chakraborty</dc:creator><dc:creator> Jacob I Beaudway</dc:creator><dc:creator> Elizabeth J Imhoff</dc:creator><dc:creator> Cameron F Keeler</dc:creator><dc:creator> Maren M McChesney</dc:creator><dc:creator> Haishal H Patel</dc:creator><dc:creator> Sahil P Patel</dc:creator><dc:creator> Megan T Thai</dc:creator><dc:creator> David A Bennett</dc:creator><dc:creator> Manolis Kellis</dc:creator><dc:creator> Li-Huei Tsai</dc:creator><dc:date> 2023-09-29</dc:date><dc:source> Cell</dc:source><dc:title> Single-cell atlas reveals correlates of high cognitive function, dementia, and resilience to Alzheimer&#39;s disease pathology</dc:title><dc:identifier> pmid:37774677</dc:identifier><dc:identifier> doi:10.1016/j.cell.2023.08.039</dc:identifier></item></channel></rss>